Citigroup’s X4 Pharmaceuticals XFOR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.45K | Sell |
762
-3,317
| -81% | -$6.3K | ﹤0.01% | 4634 |
|
|
2025
Q1 | $28.9K | Sell |
4,079
-495
| -11% | -$3.51K | ﹤0.01% | 4246 |
|
|
2024
Q4 | $101K | Buy |
4,574
+405
| +10% | +$8.91K | ﹤0.01% | 3996 |
|
|
2024
Q3 | $83.7K | Buy |
4,169
+2,950
| +242% | +$59.2K | ﹤0.01% | 4076 |
|
|
2024
Q2 | $21.2K | Sell |
1,219
-3,016
| -71% | -$52.5K | ﹤0.01% | 4245 |
|
|
2024
Q1 | $177K | Buy |
4,235
+3,647
| +620% | +$152K | ﹤0.01% | 3338 |
|
|
2023
Q4 | $14.8K | Buy |
588
+586
| +29,300% | +$14.7K | ﹤0.01% | 4329 |
|
|
2023
Q3 | $75 | Sell |
2
-1,220
| -100% | -$45.8K | ﹤0.01% | 4706 |
|
|
2023
Q2 | $71.1K | Buy |
+1,222
| New | +$71.1K | ﹤0.01% | 3750 |
|
|
2021
Q3 | – | Sell |
-1
| Closed | – | – | 5534 |
|
|
2021
Q2 | $0 | Sell |
1
-35
| -97% | – | ﹤0.01% | 5657 |
|
|
2021
Q1 | $9K | Sell |
36
-65
| -64% | -$16.3K | ﹤0.01% | 5052 |
|
|
2020
Q4 | $19K | Buy |
101
+75
| +288% | +$14.1K | ﹤0.01% | 4668 |
|
|
2020
Q3 | $5K | Sell |
26
-44
| -63% | -$8.46K | ﹤0.01% | 4693 |
|
|
2020
Q2 | $20K | Sell |
70
-35
| -33% | -$10K | ﹤0.01% | 4264 |
|
|
2020
Q1 | $31K | Buy |
105
+26
| +33% | +$7.68K | ﹤0.01% | 4124 |
|
|
2019
Q4 | $25K | Buy |
79
+59
| +295% | +$18.7K | ﹤0.01% | 4396 |
|
|
2019
Q3 | $7K | Sell |
20
-45
| -69% | -$15.8K | ﹤0.01% | 4696 |
|
|
2019
Q2 | $29K | Buy |
65
+52
| +400% | +$23.2K | ﹤0.01% | 4432 |
|
|
2019
Q1 | $6K | Buy |
13
+5
| +63% | +$2.31K | ﹤0.01% | 4866 |
|
|
2018
Q4 | $3K | Sell |
8
-694
| -99% | -$260K | ﹤0.01% | 4854 |
|
|
2018
Q3 | $205K | Buy |
702
+698
| +17,450% | +$204K | ﹤0.01% | 3143 |
|
|
2018
Q2 | $2K | Buy |
4
+1
| +33% | +$500 | ﹤0.01% | 4863 |
|
|
2018
Q1 | $14K | Sell |
3
-1
| -25% | -$4.67K | ﹤0.01% | 4374 |
|
|
2017
Q4 | $9K | Buy |
+4
| New | +$9K | ﹤0.01% | 4541 |
|